Tesla Recalls Model...
Health Care: Drugs
Jazz Pharmaceuticals PLC (JAZZ: NASDAQ)
$68.41 -1.25 | -1.79%
06/19/13 - 02:50 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 69.66 |
| 52 Week High | 72.00 |
| 52 Week Low | 43.09 |
| Avg. Daily Vol. (Mil) | 0.84 |
| Beta (3 year) | 0.60 |
| Share Related Items | |
| Mkt Cap (Mil) | 4,083.96 |
| Shares Out (Mil) | 58.63 |
| Float (Mil) | 51.90 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 2.20 |
| Current Ratio | 2.70 |
| LT Debt/ Equity | 0.36 |
| Total Debt / Equity | 0.39 |
| Valuation Ratios | |
| Price Earnings | 13.80 |
| Price/Sales | 5.96 |
| Price/Book | 3.51 |
| Price/Cash Flow | 10.50 |
| Per Share Data | |
| Earnings | 5.03 |
| Sales | 11.68 |
| Book Value | 19.82 |
| Cash Flow | 6.66 |
| Business Summary | |
|---|---|
| Jazz Pharmaceuticals PLC, is a specialty pharmaceutical company, which is focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. | |
| General Information | |
| Fourth Floor, Connaught Hous
One Burlington Road Dublin, 4 |
|
| www.jazzpharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 640 | |
| CEO: Bruce C. Cozadd | |
| Short Interest | |
| Current Month (Mil) | 2.62 |
| Previous Month (Mil) | 2.16 |
| Short Interest Ratio (Days) | 2.50 |
| Management Effectiveness | |
| Return on Equity | 26.20 |
| Return on Assets | 15.10 |
| Return on Investments | 19.30 |
| Profitability | |
| Gross Margin | 86.60 |
| EBIT Margin | 32.60 |
| Profit Margin | 44.40 |
Portfolios with JAZZ
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- UserMike
- UserHealth
- UserGFNN Stockdiagnostics 11
- Contributor10 Best-Performing Stocks i...
- UserS ACCT
- ContributorStocks Rising On Unusual Vo...
- UserGFNN Stockdiagnostics
- User201201
Latest JAZZ Headlines from TheStreet
- Jazz Reaches New 52-Week High (JAZZ) 06.14.13 | 12:06 pm
- Cramer's Top Stock Picks: LULU PVH IMAX JAZZ CHUY INFN 06.08.13 | 06:06 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 06.07.13 | 08:06 pm
- Jazz Stock Hits New 52-Week High (JAZZ) 05.30.13 | 10:05 am
- Jazz Reaches New 52-Week High (JAZZ) 05.22.13 | 10:05 am
- 3 Stocks Pulling The Health Care Sector Downward 05.08.13 | 01:05 pm
- JAZZ Crosses Below Key Moving Average Level 05.08.13 | 11:05 am
- Jazz Rises On Unusually High Volume (JAZZ) 04.17.13 | 04:04 pm
- Top Insider Trades: HLF FSYS JAZZ JMP 03.13.13 | 09:03 am
- Analysts' Actions: BTU JAZZ MYL SKUL TDG 03.11.13 | 08:03 am
Press Releases for JAZZ
- New Research Demonstrates People With Narcolepsy Face Significant Health And Economic Burden And High Rates Of Misdiagnosis - PR Newswire 06.13.13 | 08:06 am
- New Research At SLEEP 2013 Demonstrates People With Narcolepsy Face Significant Health And Economic Burden And High Rates Of Misdiagnosis - PR Newswire 06.05.13 | 07:06 am
- Jazz Pharmaceuticals Announces Participation In Upcoming Investor Events - PR Newswire 05.13.13 | 09:05 pm
- Jazz Pharmaceuticals To Report First Quarter 2013 Financial Results On May 7, 2013 - PR Newswire 04.23.13 | 04:04 pm
- Jazz Pharmaceuticals Announces Pricing Of Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.05.13 | 09:03 am
- Jazz Pharmaceuticals Announces Public Offering Of Ordinary Shares By Selling Shareholders - PR Newswire 03.04.13 | 04:03 pm
- Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March - PR Newswire 02.27.13 | 09:02 am
- Http://www.jazzpharma.com/ - Business Wire 02.26.13 | 04:02 pm
- Jazz Pharmaceuticals To Report 2012 Fourth Quarter And Full Year Financial Results On February 26, 2013 - PR Newswire 02.11.13 | 04:02 pm
- Where Opportunity Is Found - Research Report On Jazz Pharmaceuticals Plc And Spectrum Pharmaceuticals, Inc. - PR Newswire 01.23.13 | 08:01 am
Partner Headlines for JAZZ
- BioLineRx Enrolls First Patient in Study - Analyst Blog - Zacks 06.07.13 | 11:06 pm
- Avanir to Expedite AVP-786 Development - Analyst Blog - Zacks 06.07.13 | 12:06 am
- Stocks Close Another Erratic Session With Losses - Investor's Business Daily 06.04.13 | 04:06 pm
- Stocks Wrestle To Hold Gains; U.S. Silica, Generac Take Hits - Investor's Business Daily 06.04.13 | 11:06 am
- AstraZeneca Presents Olaparib Data - Analyst Blog - Zacks 06.04.13 | 12:06 am
- CRL for Endo Health's Aveed - Analyst Blog - Zacks 06.04.13 | 12:06 am
- Patent Challenge from Perrigo - Analyst Blog - Zacks 06.01.13 | 12:06 am
- Idenix Pharma Initiates Phase II Study - Analyst Blog - Zacks 05.31.13 | 11:05 pm
- IBD 50 Has Best Month In More Than A Year - Investor's Business Daily 05.31.13 | 06:05 pm
- Stocks End In Red As Selling Swells At The Close - Investor's Business Daily 05.31.13 | 04:05 pm
